NTRK2 and obesity due to melanocortin 4 receptor deficiency: To investigate the feasibility of trkB agonism as a therapeutic approach for human obesity, we conducted a series of experiments using NT4, BDNF and TrkB agonistic antibody in several species of non-human primates.